@article{dd086e9f1b6c4060a4fbc96a9a42c2d4,
title = "The solid progress of nanomedicine",
abstract = "This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.",
keywords = "CANCER, CHEMOTHERAPY, Cancer therapy, Clinical translation, Nanomedicine, Nanotechnology, PACLITAXEL, Reproducibility, THERAPY, TUMOR, 3122 Cancers, 221 Nano-technology, 317 Pharmacy",
author = "Martins, \{Jo{\~a}o Pedro\} and \{das Neves\}, Jos{\'e} and \{de la Fuente\}, Mar{\'i}a and Christian Celia and Helena Florindo and Nazende G{\"u}nday-T{\"u}reli and Amirali Popat and \{Luis Santos\}, Jos{\'e} and Fl{\'a}via Sousa and Ruth Schmid and Joy Wolfram and Bruno Sarmento and Santos, \{H{\'e}lder A.\}",
year = "2020",
month = jun,
doi = "10.1007/s13346-020-00743-2",
language = "English",
volume = "10",
pages = "726--729",
journal = "Drug delivery and translational research",
issn = "2190-393X",
publisher = "Springer",
}